# Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab

> **NCT01891552** · — · COMPLETED · sponsor: **International Group of Endovascular Oncology** · enrollment: 40 (actual)

## Conditions studied

- Colon Cancer Liver Metastasis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01891552
- **Lead sponsor:** International Group of Endovascular Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01891552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01891552, "Observational Study on Second Line Treatment of Liver Metastases With DEBIRI and Cetuximab". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01891552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*